Characterization of Tau Hyperphosphorylation in ARSACS – Dr. Anthony Hickey

In Current Research, Research in 2019 by ARSACS

The goal of this proposal is to validate the misregulation of Tau in ARSACS and establish a platform from which to explore therapeutic targeting of proteins involved in tau pathology as a treatment for ARSACS.

Grant : $98,758


Dr. Anthony Hickey, Director of UNC Catalyst for Rare Diseases, University of North Carolina

120 Mason Farm Road CB# 7356, Chapel Hill NC 27599

Tel: (919) 962-9819

Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis: